Merck beats quarterly sales estimate
Merck & Co has today posted better-than-expected second-quarter sales on strong demand for its two top-selling products, cancer immunotherapy Keytruda and human papillomavirus (HPV) vaccine Gardasil.
Business
• 01 Aug 23
